SCHEMBL6366951

SCHEMBL6366951

Nc1cccc(Sc2cccc3c2C(=O)c2cccc(Sc4cccc(N)c4)c2C3=O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.60
▸ MAPK1 P28482 2/20 0.60
▸ NSD2 O96028 2/20 0.60
▸ KDM4E B2RXH2 2/20 0.60
▸ ADORA2A P29274 3/20 0.49
▸ PDE7A Q13946 2/20 0.43
▸ ANXA2 P07355 1/20 0.38
▸ S100A10 P60903 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ PTPRC P08575 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ MEN1 O00255 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27602051 0.95 MAPK1 (0.64) MAPTMAPK1NSD2KDM4EADORA2A
SCHEMBL10608055 0.95 MAPT (0.69) MAPTMAPK1NSD2KDM4EADORA2A
SCHEMBL10608058 0.84 MAPT (0.51) MAPTMAPK1NSD2KDM4EADORA2A
SCHEMBL6365480 0.83 MAPK1 (0.64) MAPTMAPK1NSD2KDM4EADORA2A
SCHEMBL14039788 0.82 MAPT (0.73) MAPTMAPK1NSD2KDM4EADORA2A
SCHEMBL4465042 0.80 MAPT (0.89) MAPTMAPK1NSD2KDM4EADORA2A
SCHEMBL11579534 0.80 MAPT (0.75) MAPTMAPK1NSD2KDM4EADORA2A
SCHEMBL10606990 0.80 KDM4E (0.56) MAPTMAPK1NSD2KDM4EADORA2A
SCHEMBL28752267 0.79 MAPK1 (0.68) MAPTMAPK1NSD2KDM4EADORA2A
SCHEMBL17284185 0.78 MAPK1 (0.72) MAPTMAPK1NSD2KDM4EADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives HUANG HSU-SHAN (TW) 2005-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives NFE2L2, NR2F2, TFAM MAPT 4766/4885MAPK1 4421/4885NSD2 2666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback